This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

16 Dec 2010

Lundbeck Embarks on Research Initiative to Identify and Develop Therapies that May Slow or Halt the Progression of Huntington's

Lundbeck Inc. today launched a Huntington's disease (HD) research initiative to identify and ultimately commercialize therapies that may slow or halt the progression of the disease.

Related News